Ranbaxy Loses Bid To Make Generic Flomax
A U.S. federal judge has squashed an attempt by Indian generic drug maker Ranbaxy Laboratories Ltd. to make its own version of Flomax, the enlarged-prostate treatment developed by Japanese pharmaceutical firm...To view the full article, register now.
Already a subscriber? Click here to view full article